ADVERTISEMENT
ADVERTISEMENT
New Strategies for Cancer Immunotherapy
New Strategies for Cancer Immunotherapy
An expert panel will discuss the interplay between cancer and the immune system, and how researchers develop immunotherapies and other immune-supporting strategies against cancer. 
New Strategies for Cancer Immunotherapy
New Strategies for Cancer Immunotherapy

An expert panel will discuss the interplay between cancer and the immune system, and how researchers develop immunotherapies and other immune-supporting strategies against cancer. 

An expert panel will discuss the interplay between cancer and the immune system, and how researchers develop immunotherapies and other immune-supporting strategies against cancer. 

cancer vaccines

Cancer Vaccines: A Dose of Prevention
Cancer Vaccines: A Dose of Prevention
The Scientist | Aug 10, 2023 | 1 min read
Discover the latest progress behind therapeutic vaccines that boost the immune system’s cancer-killing abilities.
Illustration of a jackalope
On the Trail of the Jackalope
Michael P. Branch | Feb 14, 2022 | 5 min read
How horned rabbits led the way to the HPV vaccine
Salmonella (pink) invading a human epithelial cell (yellow)
Modified Salmonella Revs Immune Response, Combats Tumors in Mice
Natalia Mesa, PhD | Feb 3, 2022 | 5 min read
When coated with positively charged particles, the bacteria shuttled antigens out of tumors and activated the immune system, a study finds.
personalized vaccines
Infographic: Neoantigen Prediction for Personalized Vaccine Design
Jasreet Hundal and Elaine R. Mardis | Jul 15, 2019 | 3 min read
See how a computational pipeline uses next-generation sequencing data to identify genetic alterations that produce cancer-specific antigens.
custom targeted cancer vaccine
Personalized Cancer Vaccines in Clinical Trials
Jasreet Hundal and Elaine R. Mardis | Jul 15, 2019 | 10+ min read
The field is young, but predicting antigens produced by patients’ malignant cells could yield successful treatments for individuals with a range of cancer types.
Table: Personalized Cancer Vaccine Trials in the United States
Jasreet Hundal and Elaine R. Mardis | Jul 15, 2019 | 6 min read
There are currently more than two dozen ongoing Phase 1 and Phase 2 trials using different vaccine platforms such as DNA, RNA, synthetic long peptides, and dendritic cells.
Locally-Injected Immunotherapy Eradicates Tumors in Mice
Diana Kwon | Feb 1, 2018 | 2 min read
The treatment also curbed the growth of nearby metastases that did not receive the drug.
Personalized Cancer Vaccines Show Promise for Melanoma
Jef Akst | Jul 6, 2017 | 2 min read
In two early trials, vaccines tailored to the mutations in individuals’ cancers appeared to protect 12 of 19 patients against relapse. 
Gel Scaffolds for Delivery of Immunotherapies
Rachel Berkowitz | Apr 1, 2017 | 7 min read
Using biocompatible polymers to carry cancer immune therapies directly to the tumor
ADVERTISEMENT